Cognizant expands relatonship with Gilead

Cognizant (CTSH) announced an expansion of its relationship with Gilead Sciences (GILD). Under the agreement, Cognizant will manage Gilead’s global IT infrastructure, platforms, applications and advanced analytics, and lead initiatives designed to accelerate its digital transformation. The agreement includes renewal and expansion of Cognizant services for a total expected value of $800 million over the next five years. This collaboration is aimed at enabling Gilead to streamline various parts of its business with the goal of faster time to market of various medicines for life-threatening diseases, including HIV, viral hepatitis, and cancer. Cognizant anticipates leveraging the power of Generative AI to help enhance Gilead’s customer service experience.